Nishan de Silva

Nishan M.
de Silva is currently Director at Alita Pharmaceuticals, Inc. and Independent Director at Cartesian Therapeutics, Inc. Former roles include Chief Executive Officer & Director at Radionetics Oncology, Inc. (2022-2023), Chief Executive Officer & Director at AFYX Therapeutics.
AS (2020-2022), President, Chief Operating Officer & Director at Poseida Therapeutics, Inc. (2015-2018), Chief Financial Officer & Vice President-Strategy at Ligand Pharmaceuticals, Inc. (2014-2015), Independent Director at Allos Therapeutics, Inc. (2010-2011), Independent Director at Sophiris Bio, Inc. (2011-2012), Director at Talon Therapeutics, Inc. (2010-2011), and roles as Director or Independent Director at Selecta Biosciences, Inc., CONNECT, and Transposagen Biopharmaceuticals, Inc. Additional former positions include Principal at Warburg Pincus LLC and Sprout Group, and Engagement Manager & Principal at McKinsey & Co., Inc. Education includes an MBA from The Wharton School of the University of Pennsylvania, a doctorate from Perelman School of Medicine, and undergraduate studies at Harvard College.